Newron Pharmaceuticals Gets European Patent for Use of Painkiller Ralfinamide in Migraines Published: Dec 20, 2007 ZURICH (Thomson Financial) - Newron Pharmaceuticals SpA said it has received a European patent for use of its painkiller ralfinamide in migraines. Related links AFX Press This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news